nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—ABCC2—Spironolactone—dilated cardiomyopathy	0.245	0.356	CbGbCtD
Irinotecan—ABCC2—Furosemide—dilated cardiomyopathy	0.168	0.244	CbGbCtD
Irinotecan—ALB—Furosemide—dilated cardiomyopathy	0.104	0.152	CbGbCtD
Irinotecan—ABCB1—Lisinopril—dilated cardiomyopathy	0.0908	0.132	CbGbCtD
Irinotecan—ABCB1—Spironolactone—dilated cardiomyopathy	0.0799	0.116	CbGbCtD
Irinotecan—Lung neoplasm—Lisinopril—dilated cardiomyopathy	0.05	0.222	CcSEcCtD
Irinotecan—Hypovolaemia—Furosemide—dilated cardiomyopathy	0.00744	0.0331	CcSEcCtD
Irinotecan—Ulcer—Spironolactone—dilated cardiomyopathy	0.00448	0.0199	CcSEcCtD
Irinotecan—TOP1MT—heart—dilated cardiomyopathy	0.00378	0.114	CbGeAlD
Irinotecan—Lung infiltration—Lisinopril—dilated cardiomyopathy	0.00369	0.0164	CcSEcCtD
Irinotecan—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.00363	0.0161	CcSEcCtD
Irinotecan—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00333	0.0148	CcSEcCtD
Irinotecan—Thrombosis—Furosemide—dilated cardiomyopathy	0.00326	0.0145	CcSEcCtD
Irinotecan—TOP1—cardiac ventricle—dilated cardiomyopathy	0.00303	0.0918	CbGeAlD
Irinotecan—TOP1—myocardium—dilated cardiomyopathy	0.00285	0.0863	CbGeAlD
Irinotecan—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.00281	0.0125	CcSEcCtD
Irinotecan—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00277	0.0123	CcSEcCtD
Irinotecan—CES2—cardiac ventricle—dilated cardiomyopathy	0.00275	0.0833	CbGeAlD
Irinotecan—CES2—myocardium—dilated cardiomyopathy	0.00259	0.0783	CbGeAlD
Irinotecan—Renal failure—Spironolactone—dilated cardiomyopathy	0.00233	0.0104	CcSEcCtD
Irinotecan—TOP1—heart—dilated cardiomyopathy	0.00199	0.0603	CbGeAlD
Irinotecan—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00195	0.0087	CcSEcCtD
Irinotecan—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00193	0.0086	CcSEcCtD
Irinotecan—Cough increased—Lisinopril—dilated cardiomyopathy	0.00189	0.0084	CcSEcCtD
Irinotecan—Alopecia—Spironolactone—dilated cardiomyopathy	0.00188	0.00836	CcSEcCtD
Irinotecan—CES2—heart—dilated cardiomyopathy	0.00181	0.0547	CbGeAlD
Irinotecan—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00178	0.00792	CcSEcCtD
Irinotecan—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00177	0.00789	CcSEcCtD
Irinotecan—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00173	0.00769	CcSEcCtD
Irinotecan—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00173	0.00769	CcSEcCtD
Irinotecan—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00172	0.00765	CcSEcCtD
Irinotecan—TOP1—cardiac atrium—dilated cardiomyopathy	0.0017	0.0515	CbGeAlD
Irinotecan—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00168	0.00747	CcSEcCtD
Irinotecan—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00168	0.00747	CcSEcCtD
Irinotecan—Malaise—Spironolactone—dilated cardiomyopathy	0.00167	0.00743	CcSEcCtD
Irinotecan—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00166	0.00738	CcSEcCtD
Irinotecan—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00157	0.00697	CcSEcCtD
Irinotecan—Discomfort—Spironolactone—dilated cardiomyopathy	0.00156	0.00693	CcSEcCtD
Irinotecan—Dehydration—Furosemide—dilated cardiomyopathy	0.00156	0.00692	CcSEcCtD
Irinotecan—CES2—cardiac atrium—dilated cardiomyopathy	0.00155	0.0468	CbGeAlD
Irinotecan—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00153	0.0068	CcSEcCtD
Irinotecan—Confusional state—Spironolactone—dilated cardiomyopathy	0.00152	0.00678	CcSEcCtD
Irinotecan—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00152	0.00677	CcSEcCtD
Irinotecan—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00151	0.00672	CcSEcCtD
Irinotecan—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00151	0.0067	CcSEcCtD
Irinotecan—CES1—heart—dilated cardiomyopathy	0.00149	0.045	CbGeAlD
Irinotecan—ACHE—heart—dilated cardiomyopathy	0.00149	0.045	CbGeAlD
Irinotecan—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00148	0.00658	CcSEcCtD
Irinotecan—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00146	0.00648	CcSEcCtD
Irinotecan—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00142	0.00631	CcSEcCtD
Irinotecan—Injury—Lisinopril—dilated cardiomyopathy	0.00137	0.00608	CcSEcCtD
Irinotecan—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00136	0.00605	CcSEcCtD
Irinotecan—Somnolence—Spironolactone—dilated cardiomyopathy	0.00134	0.00598	CcSEcCtD
Irinotecan—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00132	0.00587	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00131	0.00581	CcSEcCtD
Irinotecan—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.0013	0.00577	CcSEcCtD
Irinotecan—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00128	0.0057	CcSEcCtD
Irinotecan—Renal failure—Furosemide—dilated cardiomyopathy	0.00127	0.00564	CcSEcCtD
Irinotecan—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00126	0.00561	CcSEcCtD
Irinotecan—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00126	0.00559	CcSEcCtD
Irinotecan—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00125	0.00554	CcSEcCtD
Irinotecan—Sweating—Furosemide—dilated cardiomyopathy	0.00124	0.0055	CcSEcCtD
Irinotecan—ABCC1—myocardium—dilated cardiomyopathy	0.00122	0.037	CbGeAlD
Irinotecan—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0012	0.00532	CcSEcCtD
Irinotecan—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00119	0.00531	CcSEcCtD
Irinotecan—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00118	0.00523	CcSEcCtD
Irinotecan—Dehydration—Lisinopril—dilated cardiomyopathy	0.00117	0.00519	CcSEcCtD
Irinotecan—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00115	0.0051	CcSEcCtD
Irinotecan—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00113	0.00503	CcSEcCtD
Irinotecan—Visual impairment—Furosemide—dilated cardiomyopathy	0.00112	0.00496	CcSEcCtD
Irinotecan—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00111	0.00495	CcSEcCtD
Irinotecan—BCHE—cardiac ventricle—dilated cardiomyopathy	0.00111	0.0337	CbGeAlD
Irinotecan—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00106	0.00473	CcSEcCtD
Irinotecan—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00106	0.0047	CcSEcCtD
Irinotecan—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00106	0.0047	CcSEcCtD
Irinotecan—Angiopathy—Furosemide—dilated cardiomyopathy	0.00105	0.00467	CcSEcCtD
Irinotecan—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00105	0.00465	CcSEcCtD
Irinotecan—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00103	0.0046	CcSEcCtD
Irinotecan—ALB—heart—dilated cardiomyopathy	0.00103	0.0313	CbGeAlD
Irinotecan—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00103	0.0046	CcSEcCtD
Irinotecan—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00101	0.00451	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00101	0.00449	CcSEcCtD
Irinotecan—Dizziness—Spironolactone—dilated cardiomyopathy	0.001	0.00445	CcSEcCtD
Irinotecan—Flatulence—Furosemide—dilated cardiomyopathy	0.000993	0.00442	CcSEcCtD
Irinotecan—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000982	0.00437	CcSEcCtD
Irinotecan—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000973	0.00433	CcSEcCtD
Irinotecan—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000969	0.00431	CcSEcCtD
Irinotecan—Vomiting—Spironolactone—dilated cardiomyopathy	0.000961	0.00428	CcSEcCtD
Irinotecan—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000954	0.00424	CcSEcCtD
Irinotecan—Rash—Spironolactone—dilated cardiomyopathy	0.000953	0.00424	CcSEcCtD
Irinotecan—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000952	0.00424	CcSEcCtD
Irinotecan—Renal failure—Lisinopril—dilated cardiomyopathy	0.000951	0.00423	CcSEcCtD
Irinotecan—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000949	0.00422	CcSEcCtD
Irinotecan—Headache—Spironolactone—dilated cardiomyopathy	0.000947	0.00421	CcSEcCtD
Irinotecan—Jaundice—Lisinopril—dilated cardiomyopathy	0.000943	0.0042	CcSEcCtD
Irinotecan—Anaemia—Furosemide—dilated cardiomyopathy	0.000931	0.00414	CcSEcCtD
Irinotecan—Sweating—Lisinopril—dilated cardiomyopathy	0.000928	0.00413	CcSEcCtD
Irinotecan—Vertigo—Furosemide—dilated cardiomyopathy	0.000905	0.00403	CcSEcCtD
Irinotecan—Leukopenia—Furosemide—dilated cardiomyopathy	0.000902	0.00401	CcSEcCtD
Irinotecan—Nausea—Spironolactone—dilated cardiomyopathy	0.000898	0.00399	CcSEcCtD
Irinotecan—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000884	0.00393	CcSEcCtD
Irinotecan—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000871	0.00387	CcSEcCtD
Irinotecan—ABCC1—heart—dilated cardiomyopathy	0.000854	0.0258	CbGeAlD
Irinotecan—Confusional state—Furosemide—dilated cardiomyopathy	0.000829	0.00369	CcSEcCtD
Irinotecan—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000823	0.00366	CcSEcCtD
Irinotecan—Shock—Furosemide—dilated cardiomyopathy	0.000809	0.0036	CcSEcCtD
Irinotecan—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000807	0.00359	CcSEcCtD
Irinotecan—Flushing—Lisinopril—dilated cardiomyopathy	0.000806	0.00359	CcSEcCtD
Irinotecan—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000805	0.00358	CcSEcCtD
Irinotecan—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000795	0.00354	CcSEcCtD
Irinotecan—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000788	0.00351	CcSEcCtD
Irinotecan—Anorexia—Furosemide—dilated cardiomyopathy	0.000784	0.00349	CcSEcCtD
Irinotecan—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000783	0.00348	CcSEcCtD
Irinotecan—Chills—Lisinopril—dilated cardiomyopathy	0.000779	0.00347	CcSEcCtD
Irinotecan—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000776	0.00345	CcSEcCtD
Irinotecan—Hypotension—Furosemide—dilated cardiomyopathy	0.000769	0.00342	CcSEcCtD
Irinotecan—Alopecia—Lisinopril—dilated cardiomyopathy	0.000768	0.00341	CcSEcCtD
Irinotecan—Flatulence—Lisinopril—dilated cardiomyopathy	0.000745	0.00331	CcSEcCtD
Irinotecan—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000739	0.00329	CcSEcCtD
Irinotecan—Back pain—Lisinopril—dilated cardiomyopathy	0.000731	0.00325	CcSEcCtD
Irinotecan—BCHE—heart—dilated cardiomyopathy	0.000731	0.0221	CbGeAlD
Irinotecan—Somnolence—Furosemide—dilated cardiomyopathy	0.000731	0.00325	CcSEcCtD
Irinotecan—ABCC1—cardiac atrium—dilated cardiomyopathy	0.00073	0.0221	CbGeAlD
Irinotecan—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000727	0.00323	CcSEcCtD
Irinotecan—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000715	0.00318	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00071	0.00316	CcSEcCtD
Irinotecan—Fatigue—Furosemide—dilated cardiomyopathy	0.000709	0.00315	CcSEcCtD
Irinotecan—ABCG2—heart—dilated cardiomyopathy	0.000707	0.0214	CbGeAlD
Irinotecan—Pain—Furosemide—dilated cardiomyopathy	0.000703	0.00313	CcSEcCtD
Irinotecan—Constipation—Furosemide—dilated cardiomyopathy	0.000703	0.00313	CcSEcCtD
Irinotecan—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000702	0.00312	CcSEcCtD
Irinotecan—Anaemia—Lisinopril—dilated cardiomyopathy	0.000699	0.00311	CcSEcCtD
Irinotecan—Malaise—Lisinopril—dilated cardiomyopathy	0.000682	0.00303	CcSEcCtD
Irinotecan—Vertigo—Lisinopril—dilated cardiomyopathy	0.000679	0.00302	CcSEcCtD
Irinotecan—Syncope—Lisinopril—dilated cardiomyopathy	0.000678	0.00302	CcSEcCtD
Irinotecan—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000678	0.00302	CcSEcCtD
Irinotecan—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000677	0.00301	CcSEcCtD
Irinotecan—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000673	0.00299	CcSEcCtD
Irinotecan—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000665	0.00296	CcSEcCtD
Irinotecan—Cough—Lisinopril—dilated cardiomyopathy	0.00066	0.00294	CcSEcCtD
Irinotecan—CYP2B6—heart—dilated cardiomyopathy	0.000652	0.0197	CbGeAlD
Irinotecan—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00065	0.00289	CcSEcCtD
Irinotecan—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00065	0.00289	CcSEcCtD
Irinotecan—Discomfort—Lisinopril—dilated cardiomyopathy	0.000636	0.00283	CcSEcCtD
Irinotecan—BCHE—cardiac atrium—dilated cardiomyopathy	0.000625	0.0189	CbGeAlD
Irinotecan—Confusional state—Lisinopril—dilated cardiomyopathy	0.000622	0.00277	CcSEcCtD
Irinotecan—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000617	0.00275	CcSEcCtD
Irinotecan—Oedema—Lisinopril—dilated cardiomyopathy	0.000617	0.00275	CcSEcCtD
Irinotecan—Infection—Lisinopril—dilated cardiomyopathy	0.000613	0.00273	CcSEcCtD
Irinotecan—Shock—Lisinopril—dilated cardiomyopathy	0.000607	0.0027	CcSEcCtD
Irinotecan—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000606	0.0027	CcSEcCtD
Irinotecan—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000604	0.00269	CcSEcCtD
Irinotecan—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000597	0.00265	CcSEcCtD
Irinotecan—Asthenia—Furosemide—dilated cardiomyopathy	0.00059	0.00263	CcSEcCtD
Irinotecan—Anorexia—Lisinopril—dilated cardiomyopathy	0.000588	0.00262	CcSEcCtD
Irinotecan—Hypotension—Lisinopril—dilated cardiomyopathy	0.000577	0.00257	CcSEcCtD
Irinotecan—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000563	0.0025	CcSEcCtD
Irinotecan—Insomnia—Lisinopril—dilated cardiomyopathy	0.000558	0.00248	CcSEcCtD
Irinotecan—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000554	0.00247	CcSEcCtD
Irinotecan—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00055	0.00245	CcSEcCtD
Irinotecan—Somnolence—Lisinopril—dilated cardiomyopathy	0.000549	0.00244	CcSEcCtD
Irinotecan—Dizziness—Furosemide—dilated cardiomyopathy	0.000544	0.00242	CcSEcCtD
Irinotecan—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000543	0.00242	CcSEcCtD
Irinotecan—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000536	0.00239	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000533	0.00237	CcSEcCtD
Irinotecan—Fatigue—Lisinopril—dilated cardiomyopathy	0.000532	0.00237	CcSEcCtD
Irinotecan—Pain—Lisinopril—dilated cardiomyopathy	0.000528	0.00235	CcSEcCtD
Irinotecan—Constipation—Lisinopril—dilated cardiomyopathy	0.000528	0.00235	CcSEcCtD
Irinotecan—Vomiting—Furosemide—dilated cardiomyopathy	0.000523	0.00233	CcSEcCtD
Irinotecan—Rash—Furosemide—dilated cardiomyopathy	0.000519	0.00231	CcSEcCtD
Irinotecan—Dermatitis—Furosemide—dilated cardiomyopathy	0.000518	0.0023	CcSEcCtD
Irinotecan—Headache—Furosemide—dilated cardiomyopathy	0.000515	0.00229	CcSEcCtD
Irinotecan—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000509	0.00226	CcSEcCtD
Irinotecan—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000505	0.00224	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00049	0.00903	CbGpPWpGaD
Irinotecan—Nausea—Furosemide—dilated cardiomyopathy	0.000489	0.00217	CcSEcCtD
Irinotecan—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000488	0.00217	CcSEcCtD
Irinotecan—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000488	0.00217	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000473	0.00871	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000463	0.00854	CbGpPWpGaD
Irinotecan—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000455	0.00202	CcSEcCtD
Irinotecan—TOP1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000454	0.00836	CbGpPWpGaD
Irinotecan—Asthenia—Lisinopril—dilated cardiomyopathy	0.000443	0.00197	CcSEcCtD
Irinotecan—ACHE—Monoamine Transport—AGT—dilated cardiomyopathy	0.000437	0.00805	CbGpPWpGaD
Irinotecan—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000422	0.00188	CcSEcCtD
Irinotecan—Dizziness—Lisinopril—dilated cardiomyopathy	0.000408	0.00182	CcSEcCtD
Irinotecan—Vomiting—Lisinopril—dilated cardiomyopathy	0.000392	0.00175	CcSEcCtD
Irinotecan—Rash—Lisinopril—dilated cardiomyopathy	0.000389	0.00173	CcSEcCtD
Irinotecan—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000389	0.00173	CcSEcCtD
Irinotecan—Headache—Lisinopril—dilated cardiomyopathy	0.000387	0.00172	CcSEcCtD
Irinotecan—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000367	0.00676	CbGpPWpGaD
Irinotecan—Nausea—Lisinopril—dilated cardiomyopathy	0.000367	0.00163	CcSEcCtD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000358	0.0066	CbGpPWpGaD
Irinotecan—SLC22A3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000355	0.00655	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000349	0.00644	CbGpPWpGaD
Irinotecan—ABCB1—heart—dilated cardiomyopathy	0.000349	0.0105	CbGeAlD
Irinotecan—ABCC1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000319	0.00588	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000318	0.00586	CbGpPWpGaD
Irinotecan—ACHE—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.000315	0.00581	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000308	0.00567	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000307	0.00566	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000303	0.00558	CbGpPWpGaD
Irinotecan—BCHE—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.000281	0.00518	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000274	0.00506	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.00027	0.00498	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000258	0.00475	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—ABCC9—dilated cardiomyopathy	0.000246	0.00453	CbGpPWpGaD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000243	0.00448	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—ACTN2—dilated cardiomyopathy	0.000236	0.00434	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—ABCC9—dilated cardiomyopathy	0.000219	0.00404	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000216	0.00397	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000211	0.00388	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—ACTN2—dilated cardiomyopathy	0.00021	0.00387	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000205	0.00377	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000203	0.00374	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000201	0.0037	CbGpPWpGaD
Irinotecan—ACHE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.0002	0.00368	CbGpPWpGaD
Irinotecan—ACHE—Monoamine Transport—TNF—dilated cardiomyopathy	0.000198	0.00365	CbGpPWpGaD
Irinotecan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.000198	0.00364	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000197	0.00364	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000192	0.00355	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000192	0.00355	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000188	0.00346	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000186	0.00342	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000186	0.00342	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000181	0.00333	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000181	0.00333	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000181	0.00333	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000179	0.00329	CbGpPWpGaD
Irinotecan—BCHE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.000178	0.00329	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000176	0.00325	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000175	0.00323	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000175	0.00323	CbGpPWpGaD
Irinotecan—UGT1A9—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000171	0.00316	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000168	0.00309	CbGpPWpGaD
Irinotecan—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000168	0.00309	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000163	0.003	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000156	0.00288	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000156	0.00288	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000156	0.00287	CbGpPWpGaD
Irinotecan—UGT1A9—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000154	0.00284	CbGpPWpGaD
Irinotecan—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000151	0.00278	CbGpPWpGaD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000148	0.00272	CbGpPWpGaD
Irinotecan—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000148	0.00272	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000145	0.00268	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000141	0.0026	CbGpPWpGaD
Irinotecan—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000141	0.00259	CbGpPWpGaD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000141	0.00259	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000139	0.00256	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000139	0.00256	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000135	0.00249	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000134	0.00246	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000132	0.00243	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000132	0.00243	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000131	0.00242	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00013	0.0024	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00013	0.0024	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000127	0.00234	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000124	0.00228	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000124	0.00228	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000122	0.00225	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000122	0.00225	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000121	0.00223	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00012	0.00221	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000118	0.00217	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000116	0.00213	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000116	0.00213	CbGpPWpGaD
Irinotecan—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000116	0.00213	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000115	0.00213	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000115	0.00212	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—TAZ—dilated cardiomyopathy	0.000115	0.00211	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000114	0.00211	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000114	0.00211	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000112	0.00206	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.00011	0.00203	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00011	0.00203	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.00011	0.00202	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000109	0.00202	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000107	0.00197	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000106	0.00196	CbGpPWpGaD
Irinotecan—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000104	0.00192	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—SDHA—dilated cardiomyopathy	0.000104	0.00191	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000102	0.00188	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000101	0.00186	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	9.85e-05	0.00182	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ANKRD1—dilated cardiomyopathy	9.61e-05	0.00177	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ANKRD1—dilated cardiomyopathy	9.11e-05	0.00168	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ANKRD1—dilated cardiomyopathy	9.11e-05	0.00168	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—TAZ—dilated cardiomyopathy	9.03e-05	0.00166	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	8.79e-05	0.00162	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ANKRD1—dilated cardiomyopathy	8.57e-05	0.00158	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—TAZ—dilated cardiomyopathy	8.57e-05	0.00158	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—TAZ—dilated cardiomyopathy	8.57e-05	0.00158	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TTN—dilated cardiomyopathy	8.39e-05	0.00155	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	8.35e-05	0.00154	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	8.26e-05	0.00152	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—SDHA—dilated cardiomyopathy	8.17e-05	0.00151	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—TAZ—dilated cardiomyopathy	8.06e-05	0.00148	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	7.85e-05	0.00145	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—SDHA—dilated cardiomyopathy	7.75e-05	0.00143	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—SDHA—dilated cardiomyopathy	7.75e-05	0.00143	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	7.73e-05	0.00143	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	7.67e-05	0.00141	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	7.47e-05	0.00138	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—SDHA—dilated cardiomyopathy	7.29e-05	0.00134	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	7.27e-05	0.00134	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	7.27e-05	0.00134	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	7.26e-05	0.00134	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.26e-05	0.00134	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	7.21e-05	0.00133	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	7.1e-05	0.00131	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.06e-05	0.0013	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.06e-05	0.0013	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7e-05	0.00129	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	6.9e-05	0.00127	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	6.77e-05	0.00125	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	6.58e-05	0.00121	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.57e-05	0.00121	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	6.52e-05	0.0012	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.36e-05	0.00117	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	6.24e-05	0.00115	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.19e-05	0.00114	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.19e-05	0.00114	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VCL—dilated cardiomyopathy	6.18e-05	0.00114	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	6.15e-05	0.00113	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—ACE—dilated cardiomyopathy	5.95e-05	0.0011	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.75e-05	0.00106	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	5.67e-05	0.00104	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	5.54e-05	0.00102	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	5.51e-05	0.00102	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—RAF1—dilated cardiomyopathy	5.36e-05	0.000988	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	5.33e-05	0.000982	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—ACE—dilated cardiomyopathy	5.31e-05	0.000979	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	5.21e-05	0.00096	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	5.14e-05	0.000947	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	5.04e-05	0.000929	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.98e-05	0.000918	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.98e-05	0.000917	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	4.86e-05	0.000896	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.85e-05	0.000894	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	4.84e-05	0.000892	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	4.82e-05	0.000888	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—RAF1—dilated cardiomyopathy	4.78e-05	0.000881	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	4.77e-05	0.000879	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.77e-05	0.000878	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.74e-05	0.000874	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.73e-05	0.000871	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	4.71e-05	0.000868	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.6e-05	0.000848	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NPPA—dilated cardiomyopathy	4.57e-05	0.000842	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.56e-05	0.00084	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TAZ—dilated cardiomyopathy	4.49e-05	0.000827	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.44e-05	0.000819	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.44e-05	0.000818	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PSEN2—dilated cardiomyopathy	4.42e-05	0.000815	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	4.38e-05	0.000807	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.37e-05	0.000805	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.33e-05	0.000798	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.33e-05	0.000798	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.22e-05	0.000777	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	4.18e-05	0.000771	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	4.18e-05	0.00077	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.15e-05	0.000764	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SDHA—dilated cardiomyopathy	4.06e-05	0.000748	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4e-05	0.000737	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.93e-05	0.000724	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.9e-05	0.000718	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.8e-05	0.0007	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—AGT—dilated cardiomyopathy	3.77e-05	0.000696	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.66e-05	0.000675	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	3.56e-05	0.000655	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—AGT—dilated cardiomyopathy	3.37e-05	0.000621	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	3.21e-05	0.000591	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.16e-05	0.000582	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	3.1e-05	0.000572	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GPX1—dilated cardiomyopathy	2.82e-05	0.000519	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CD36—dilated cardiomyopathy	2.75e-05	0.000506	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.67e-05	0.000492	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—CD36—dilated cardiomyopathy	2.65e-05	0.000488	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.64e-05	0.000486	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.58e-05	0.000475	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.51e-05	0.000462	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—RAC1—dilated cardiomyopathy	2.5e-05	0.00046	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.48e-05	0.000456	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AGT—dilated cardiomyopathy	2.47e-05	0.000455	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.42e-05	0.000446	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.41e-05	0.000444	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.32e-05	0.000428	CbGpPWpGaD
Irinotecan—ABCC1—Disease—RAC1—dilated cardiomyopathy	2.22e-05	0.00041	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GPX1—dilated cardiomyopathy	2.22e-05	0.000409	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.19e-05	0.000404	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.17e-05	0.0004	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.17e-05	0.000399	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CD36—dilated cardiomyopathy	2.16e-05	0.000398	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GPX1—dilated cardiomyopathy	2.11e-05	0.000388	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GPX1—dilated cardiomyopathy	2.11e-05	0.000388	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.06e-05	0.00038	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CD36—dilated cardiomyopathy	2.05e-05	0.000378	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CD36—dilated cardiomyopathy	2.05e-05	0.000378	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	2.03e-05	0.000374	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GPX1—dilated cardiomyopathy	1.98e-05	0.000365	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CD36—dilated cardiomyopathy	1.98e-05	0.000364	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AGT—dilated cardiomyopathy	1.95e-05	0.000359	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	1.93e-05	0.000355	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CD36—dilated cardiomyopathy	1.93e-05	0.000355	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	1.88e-05	0.000346	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AGT—dilated cardiomyopathy	1.85e-05	0.00034	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AGT—dilated cardiomyopathy	1.85e-05	0.00034	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	1.79e-05	0.000329	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AGT—dilated cardiomyopathy	1.78e-05	0.000328	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	1.77e-05	0.000326	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CD36—dilated cardiomyopathy	1.74e-05	0.000321	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AGT—dilated cardiomyopathy	1.74e-05	0.00032	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	1.72e-05	0.000318	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	1.69e-05	0.000312	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.65e-05	0.000305	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AGT—dilated cardiomyopathy	1.57e-05	0.000289	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	1.55e-05	0.000286	CbGpPWpGaD
Irinotecan—ABCC1—Disease—RAF1—dilated cardiomyopathy	1.48e-05	0.000272	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.43e-05	0.000264	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	1.31e-05	0.000241	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.28e-05	0.000236	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	1.28e-05	0.000235	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.25e-05	0.000231	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	1.25e-05	0.00023	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	1.15e-05	0.000212	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	1.12e-05	0.000207	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GPX1—dilated cardiomyopathy	1.1e-05	0.000203	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CD36—dilated cardiomyopathy	1.07e-05	0.000198	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—dilated cardiomyopathy	1.01e-05	0.000186	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AGT—dilated cardiomyopathy	9.67e-06	0.000178	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	9.66e-06	0.000178	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CD36—dilated cardiomyopathy	9.41e-06	0.000173	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AGT—dilated cardiomyopathy	8.47e-06	0.000156	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.95e-06	0.00011	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.79e-06	0.000107	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.22e-06	9.61e-05	CbGpPWpGaD
